Español
If there is one word that distinguishes OLIGOFASTX and its philosophy, it is innovation. Thanks to our research efforts, we are able to advance our objective, which is none other than to improve the quality of life of patients affected by rare diseases that have no treatment. And this desire for innovation leads us to […]
Category Archives: Uncategorized
03
Feb
Feb
As it could not be otherwise, from Oligofastx we join in the celebration of the World Cancer Day, February 4, promoted by The World Cancer Society World Health Organization the International Agency for Research on Cancer (IARC) and the International Union Against Cancer (UICC) with the aim of raising awareness and mobilizing society to advance […]
27
Jan
Jan
Leber’s congenital amaurosis (LCA) is an eye disease that primarily affects the retina, the inner eye tissue on which images are projected and where light signals are converted into electrical impulses reaching the brain and generating vision. It is described as the sudden loss of vision in one of the two eyes due to the […]
Leber’s congenital amaurosis (LCA) is an eye disease that primarily affects the retina, the inner eye tissue on which images are projected and where light signals are converted into electrical impulses reaching the brain and generating vision. It is described as the sudden loss of vision in one of the two eyes due to the […]
The last few years have been a true revolution in terms of discoveries and initiatives linked to the world of oligonucleotides, and all eyes and hopes continue to focus in the same direction in the new year 2023. It is clear that the research being carried out in the scientific world is yielding results. In […]
28
Dec
Dec
In the last days of the year, it is time to review everything we have done so far and plan for the coming months. The year 2022 has been very special for Oligofastx, because after the start date in October 2021 and the final resolution of CDTI on December 28, 2021, the project has become […]
International Biotechnology Day 2024, Uncategorized
Oligonucleotides, the language of life in small doses
12
Dec
Dec
A technological revolution can start with a key concept, the application of an equation or, often, with the development of a particular material. Steels, alloys, concretes, liquid fuels, semiconductors or polymers are examples that changed the history of mankind and today are ubiquitous in our lives. The pharmaceutical industry is no different. Thus, the ability […]
26
Oct
Oct
Thyroid cancer is a common malignancy of the endocrine system. There are four types: Papillary thyroid cancer is the most common of all thyroid cancers. Follicular thyroid cancer accounts for 10% of thyroid cancers. Medullary thyroid cancer represents 2% of thyroid cancers. Anaplastic thyroid cancer is the most advanced and aggressive of the thyroid cancers. […]
20
Oct
Oct
Today we are going to talk about one of those diseases classified as rare, for which there is, as yet, no solution. It is one of the diseases we are working on and researching at Oligofastx: Guillain-Barré syndrome. Guillain-Barré syndrome (GBS) is a neurological disorder in which the body’s immune system attacks the peripheral nervous […]